Drainage Implants in Surgical Management of Pediatric Glaucoma
Authors:
I. Krejčířová; R. Autrata; J. Řehůřek
Authors‘ workplace:
Dětská oční klinika LF MU a FN Brno, přednosta doc. MUDr. Rudolf Autrata, CSc., MBA
Published in:
Čes. a slov. Oftal., 65, 2009, No. 3, p. 79-86
Overview
Purpose:
To evaluate the effectiveness and safety of glaucoma drainage implants (Molteno and Baerveldt devices) in primary and secondary childhood glaucomas refractory to conventional surgical treatments and medical therapy.
Patients and Methods:
Retrospective study included 76 children (76 eyes) younger than 18 years who underwent glaucoma drainage device (GDD) implantation in our clinic between 1990 and 2004. The mean age at time of surgery was 6.9 5.3 years (range: 4months to 17.5 years). Intraocular pressure (IOP), visual acuity, corneal diameter, axial length, intraoperative and postoperative complications and number of glaucoma medications were evaluated. Criteria for success were defined as IOP between 7 and 22 mmHg with or without glaucoma medications, no further glaucoma surgery, and the absence of visually threatening complications, no loss of light perception. Results were compared for children with primary and secondary glaucomas. The mean follow-up was 7.1 6.5 years (range: 1.6 to 15.2 years).
Results:
Mean preoperative and postoperative IOP was 33.6 11.4 mmHg and 17.1 6.5 mmHg (p 0.001), respectively. Kaplan-Meier survival analysis showed cumulative probability of success: 93% at 6 months, 91% at 1 year, 82% at 2 years, 76% at 3 years, 71% at 4 years, 67% at 5 years and 65% at six years. There was no difference between primary (n = 31 eyes) and secondary glaucoma (n = 45 eyes) patients in terms of cumulative success (p = 0.186), final IOP, number of medications, or length of follow-up. On average, the GDI surgery was successful for a mean period of 6.7 years. Fourteen eyes of 76 (18.4%) failed with these causes: 10 eyes with uncontrolled IOP, 2 eyes of retinal detachment and 2 eyes with no light perception. Statistical regression model did not show influence of gender and previous surgery. Lower age at the time of surgery was found to be associated with higher probability of treatment failure.
Conclusion:
Molteno and Baerveldt glaucoma drainage implants surgery seems to be safe and effective treatment for primary and secondary pediatric glaucoma refractive to the initial surgical procedure and medical therapy.
Key words:
glaucoma drainage implant, pediatric glaucoma, intraocular pressure, Molteno implant, Baerveldt implant
Sources
1. Al-Hazmi, A., Zwann, J., Awad, A. et al.: Effectiveness and complications of mitomycin C use during pediatric glaucoma surgery, Ophthalmology, 105, 1998: 1915–1920
2. Al-Hazmi, A., Awad, A., Zwaan, J. et al.: Correlation between surgical success rate and severity of congenital glaucoma, Br. J. Ophthalmol., 89, 2005:449–453
3. Anderson, DR.: Trabeculotomy compared to goniotomy for glaucoma in children, Ophthalmology, 90, 1983: 805–806
4. Ayyala, RS., Zurakowski, D., Monshizadeh, R. et al.: Comparison of double-plate Molteno and Ahmed glaucoma valve in patients with advaneed uncontrolled glaucoma, Ophthalmic. Surg. Lasers, 33, 2002: 94-101
5. Azuara-Blanco, A., Wilson, RP., Spaeth, GL. et al.: Filtration procedures supplemented with mitomycin C in the management of childhood glaucoma, Br. J. Ophthalmol., 83, 1999:151–156
6. Beck, AD., Freedman, S., Kamer, J. et al.: Aqueous shunt devices compared with trabeculectomy with mitomycin-C for children in the first two years of life, Am. J. Ophthalmol., 136, 2003: 994–1000
7. Bock, CJ., Freedman, SF., Buckley, EG., et al.: Transscleral diode laser cyclophotocoagulation for refractory pediatric glaucomas, J. Pediatr. Ophthalmol. Strabismus, 34, 1997: 235–239
8. Budenz, DL., Sakamoto, D., Eliezer, R. et al.: Two-staged Baerveldt glaucoma implant for childhood glaucoma associated with Sturge-Weber syndrome, Ophthalmology, 107, 2000: 2105–2110
9. Budenz, DL., Gedde, SJ., Brandt, JD. et al.: Baerveldt glaucoma implant in the management of refractory childhood glaucomas, Ophthalmology, 111, 2004: 2204–2210
10. Burke, IP., Bowell, R.: Primary trabeculectomy in congenital glaucoma, Br. J. Ophthalmol., 73,1989: 188–190
11. Christmann, LM., Wilson, ME.: Motility disturbances after Molteno implants, J. Pediatr. Ophthalmol. Strabismus, 29,1992: 44- 48
12. Debnath, SC., Teiehmann, KD., Salamah, K.: Trabeculectomy versus trabeculotomy in congenital glaucoma, Br. J. Ophthalmol., 74, 1989: 608–611
13. Djodeyre, MR., Penalta, Calvo, J., Abelairas, Gomez, J.: Clinical evaluation and risk factors of time to failure of Ahmed Glaucoma Valve implant in pediatric patients, Ophthalmology, 108, 2001: 614–620
14. Eid, TE., Katz, U., Spaeth, OL. et al.: Long-term effects of tube-shunt procedures on management of refractory childhood glaucomas, Ophthalmology, 104,1997: 1011–1016
15. Englert, JA., Freedman, SF., Cox, TA.: The Ahmed valve in refrac tory pediatric glaucoma, Am. J. Ophthalmol., 127, 1999: 34–42
16. Fellenbaum, PS., Sidoti, PA., Heuer, DK. et al.: Experience with the Baerveldt implant in young patients with complicated glaucomas, J. Glaucoma, 4, 1995: 91–97
17. Freedman, J., Rubin, B.: Molteno implants as a treatment for refractory glaucoma in black patiens, Arch. Ophthalmol., 109, 1991: 1417–1420
18. Freedman, SF., McCormick, K., Cox, TA.: Mitomycin C-augmented trabeculectomy with postoperative wound modulation in pediatric glaucoma. J AAPOS, 3, 1999: 117–124
19. FuIcher, T., Chan, J., Lanigan, B. et al.: Long term follow up of primary trabeculectomy for infantile glaucoma, Br. J. Ophthalmol., 80, 1996: 499–502
20. Gedde, SI., Scott, ID.,Tabandch, H. et al.: Late endophthalmitis associated with glaucoma drainage implants, Ophthalmology, 108, 2001: 1323–1327
21. Hodkin, MJ., Goldblatt, WS., Burgoyne, CF., et al.: Early clinical experience with the Baerveldt implant in complicated glaucomas, Am. J. Ophthalmol., 120, 1995: 32–40
22. Hong, CH., Arosemena, A ., Zurakowski, D. et al.: Glaucoma drainage devices: a systematic literature review and current controversies, Surv. Ophthalmol., 50, 2005: 48–60
23. Ishida, K., Mandal, AK., Netland, PA.: Glaucoma drainage implants in pediatric patients, Ophthalmol. Clin. North Am., 18, 2005: 431–442
24. Kirwan, JF., Shah, P., Khaw P.: Diode laser cyclophotocoagulation: role in the management of refractory pediatric glaucomas, Ophthalmology, 109, 2002: 316–323
25. Lloyd, MA, Sedlak, T., Heuer, DK., et al.: Clinical experience with the single-plate Molteno implant in complicated glaucomas, Update of a pilot study, Ophthalmology, 99, 1992: 679–687
26. Mandal, AK., Walton, OS., John T., et al.(1997): Mitomycin C-augmented trabeculectomy in refractory congenital glaucoma, Ophthalmology, 104, 1997: 996–1003
27. Mandal, AK., Prasat, K., Naduvilath, TJ.: Surgical results and complications of mitomycin C-augmented trabeculectomy in refractory developmental glaucoma, Ophthalmic. Surg. Lasers, 30, 1999: 473–480
28. McPherson, SD. Jr., Berry, DP.: Goniotomy vs external trabeculotomy for developmental glaucoma, Am. J. Ophthalmol., 95, 1983: 427–431
29. Mills, RP., Reynolds, A., Edmond, JM., et al.: Long-term survival of Molteno glaucoma drainage device, Ophthalmology, 103, 1996: 299–305
30. Molteno, ACB., Van Biljon, O., Aneker, E.: Two-stage insertion of glaucoma drainage implants, Trans. Ophthalmol. Soc. N Z, 31, 1979: 17–26
31. Morad, Y., Donaldson, CE., Kim, YM., et al.: The Ahmed drainage implant in the treatment of pediatric glaucoma, Am. J. Ophthalmol.,135, 2003: 821–829
32. Munoz, M., Tomey, KF., Traverso, C., et al.: Clinical experience with the Molteno implant in advanced infantile glaucoma, J. Pediatr. Ophthalmol. Strabismus, 28, 1991: 68–72
33. Munoz, M., Parrish, RK ll.: Strabismus following implantation of Baerveldt drainage devices, Arch. Ophthalmol., 111, 1993, 1: 1096–1099
34. Nesher, R., Sherwood, MB., Kass, MA., et al.: Molteno implants in children, J. Glaucoma, 1,1992: 228-232
35. Netland, PA., Walton, DS.: Glaucoma drainage implants in pediatric patients, Ophthalmic. Surg., 24,1993: 723–729
36. Pereira, MLM., Araujo, SV., Wilson, RP., et al.: Aqueous shunt for intractable glaucoma in infants, Ophthalmic. Surg. Lasers, 33, 2002: 19–29
37. Phelan, MJ., Higginbotham, EJ.: Contact transscleral Nd:YAG laser cyclophotocoagulation for the treatment of refractory pediatric glaucoma, Ophthalmic. Surg. Lasers, 26,1995: 401–403
38. Rodrigues, AM., Junior, APOD., Montezano, FT., et al.: Comparison between results of trabeculectomy in primary congenital glaucoma with and without the use of mitomycin C, J. Glaucoma, 13, 2004: 228–232
39. Rolim de Moura, C., Fraser-Bell, S., Slout, A., et al.: Experience with the Baerveldt glaucoma implant in the management of pediatric glaucoma., Am. J. Ophthalmol., 139,2005: 847–854
40. Sidoti, PA., Belmonte, SJ., Liebmann, JM., et al.: Trabeculectomy with mitomycin C in the treatment of pediatric glaucomas, Ophthalmology, 107,2000: 422–429
41. Siegner, SW., Netland, PA., Urban, RC. Jr., et al.: Clinical experience with the Baerveldt glaucoma drainage implant, Ophthalmology, 102, 1995:1298–1307
42. Sturmer, J., Broadway, DC., Hitehings, RA.: Young patient trabeculectomy. Assessment of risk factors for failure, Ophthalmology, 100, 1993: 928–939
43. Susanna, R. Jr., Nieolela, MT., Takahashi, WY.: Mitomycin C as adjunctive therapy with glaucoma implant surgery, Ophthalmic. Surg., 25, 1994: 458–462
44. Waheed, S., Ritterband, DC., Greenfield, OS., et al.: Bleb-related ocular infection in children after trabeculectomy with mitomycin C, Ophthalmology, 104, 1997: 2117–2120
Labels
OphthalmologyArticle was published in
Czech and Slovak Ophthalmology
2009 Issue 3
Most read in this issue
- Examination of the Acute Central Retinal Artery Occlusion (CRAO) by Means of Optical Coherence Tomography (OCT3)
- Changes in the Retinal Nerve Fiber Layer in Non-Arteritic Anterior Ischemic Optic Neuropathy Revealed by Means of the Optical Coherence Tomography
- Awareness and Quality of Life in Patients with Glaucoma
- Analysis of Prognostic Factors of Anatomical and Functional Results of Idiopathic Macular Hole Surgery